Equity Mates podcast

Hello all,

I’ve had to reschedule the market update to 11am tomorrow, please register here and/or send through any questions by replying to this email. I’ll record and post it on our Youtube and Spotify channels.

So far this week semiconductors have traded strongly in a weak market, and it seems OpenAI is struggling to keep up with demand for their excellent new model Astra:

But all eyes are on bond yields which are breaking out to ten year highs:

In the meantime, here are notes from the Equity Mates podcast above:

Michael Frazis is back to unpack a market moving faster than ever. From cracks appearing in the AI infrastructure trade and a potential software comeback, to personalised cancer vaccines and the evolution of his own investing strategy, Michael explains why he’s moved from simply holding great growth companies to systematically taking profits and managing momentum. Plus, we dig into Nvidia’s biggest long-term threat, why Apple may have played the AI boom perfectly, and the thinking behind Frazis Capital Partners’ new ROAR Active ETF.

In this episode:

00:00 Why markets could be entering a more volatile era
02:27 The AI trade, leverage & the Ashenbrenner blow-up
08:11 Is the AI infrastructure boom starting to crack?
12:25 Cheaper AI models, China & why Apple may be the winner
16:50 The software comeback & where Michael sees opportunities
22:17 Michael Frazis’ new rules for growth and momentum investing
39:25 GLP-1s, Moderna & the next wave of biotech breakthroughs
46:49 Why Frazis Capital launched the ROAR Active ETF

Stocks & ETFs Mentioned: Frazis Capital Partners ROAR Active ETF (ASX: ROAR), Nvidia (NASDAQ: NVDA), Broadcom (NASDAQ: AVGO), Apple (NASDAQ: AAPL), Alphabet (NASDAQ: GOOGL), Meta Platforms (NASDAQ: META), Amazon (NASDAQ: AMZN), Microsoft (NASDAQ: MSFT), Taiwan Semiconductor Manufacturing Company (NYSE: TSM), Alibaba Group (NYSE: BABA), Atlassian (NASDAQ: TEAM), WiseTech Global (ASX: WTC), Xero (ASX: XRO), REA Group (ASX: REA), Datadog (NASDAQ: DDOG), Tesla (NASDAQ: TSLA), AMD (NASDAQ: AMD), Palantir Technologies (NASDAQ: PLTR), Wesfarmers (ASX: WES), Commonwealth Bank (ASX: CBA), Eli Lilly (NYSE: LLY), Novo Nordisk (NYSE: NVO), Moderna (NASDAQ: MRNA), Tempus AI (NASDAQ: TEM), Clarity Pharmaceuticals (ASX: CU6)

Mike